Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allopurinol for regression of left ventricular hypertrophy and vascular dysfunction in chronic kidney disease
2007-004760-49Phase 4Completed
- Sponsor
- University of Dundee
- Start
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of allopurinol in chronic kidney disease (CKD), left ventricular hypertrophy (LVH), endothelial dysfunction and 1 more, sponsored by University of Dundee. Primary endpoint: Left ventricular hypertrophy regression on cardiac MRI. Started Dec 2007; status: completed.
02
Drugs
allopurinol
03
Conditions
chronic kidney disease (CKD)left ventricular hypertrophy (LVH)endothelial dysfunctioncardiac morbidity
Beyond the preview
Go deeper on 2007-004760-49.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004760-49.